27.02.2024 - BOSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) - Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will participate in a .